Banner

Polycystic Ovarian Syndrome Treatment Global Market Report 2023 – By Drug Type (Oral Contraceptives, Ornithine Decarboxylase Inhibitors, InsulinSensitizing Agents, AntiDepressants, Diuretics, Aromatase Inhibitors), By Surgery Type (Ovarian Wedge Resection, Laparoscopic Ovarian Drilling), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Gynecology Centers, Feminist Health Centers) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | SKU CODE : r524 | Delivery Time: 2-3 business days | Format :


Polycystic ovarian syndrome is a disorder in which hormones are out of control for females and they have male hormones that are higher than normal, which causes them to skip menstrual periods and makes pregnancy more difficult for them.

The main drug types in the polycystic ovarian syndrome treatment market are oral contraceptives, ornithine decarboxylase inhibitors, insulin-sensitizing agents, anti-depressants, diuretics, and aromatase inhibitors. Oral contraceptives are hormone-based drugs that are taken orally to prevent pregnancy. They prevent pregnancy by slowing ovulation and preventing sperm from entering the cervix. The various surgery types include ovarian wedge resection and laparoscopic ovarian drilling, which are performed in hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, and feminist health centers.

The polycystic ovarian syndrome treatment market research report is one of a series of new reports from The Business Research Company that provides polycystic ovarian syndrome treatment market statistics, including polycystic ovarian syndrome treatment industry global market size, regional shares, competitors with a polycystic ovarian syndrome treatment market share, detailed polycystic ovarian syndrome treatment market segments, market trends and opportunities, and any further data you may need to thrive in the polycystic ovarian syndrome treatment industry. This polycystic ovarian syndrome treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global polycystic ovarian syndrome treatment market will grow from $4.26 billion in 2022 to $4.49 billion in 2023 at a compound annual growth rate (CAGR) of 5.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global polycystic ovarian syndrome treatment market is expected to grow to $5.66 billion in 2027 at a CAGR of 5.9%.

The global rise in genetic and hormonal disorders is a key factor driving the growth of the polycystic ovarian syndrome (PCOS) treatment market. PCOS is a prevalent hormonal disorder among premenopausal women worldwide, with reproductive, endocrine, and metabolic abnormalities. The PCOS prevalence ranges from 2.2% to 26% globally and is highly variable. In China, the figures range between 2% to 7.5% and 6.3% in Sri Lanka, 9.13% in south India and 22.5% in Maharashtra. The rise in genetic and hormonal disorders globally is expected to increase the growth of the polycystic ovarian syndrome treatment market.

Lack of drugs approved by regulatory bodies such as FDA (Food and Drug Administration) among many countries is a key factor hampering the growth of the polycystic ovarian syndrome treatment market. FDA has not approved pharmacological treatment for use in adolescents with PCOS. However, some pharmacological interventions are used to treat PCOS symptoms. For instance, rimonabant, a key appetite suppressant cannabinoid CB1 receptor antagonist was not approved by the United States Food and Drug Administration (FDA) in the USA due to concerns about suicidal ideation and drug overdoses. Moreover, Minoxidil is the only drug approved by FDA, used for the treatment of female pattern baldness. Therefore, the lack of regulatory body approved drugs in many countries is a key factor restraining the growth of the polycystic ovarian syndrome treatment market.

Laparoscopic ovarian drilling is a major trend driving the growth of the polycystic ovarian syndrome treatment market. Laparoscopic ovarian drilling is a surgical treatment performed by doctors in critical conditions that can cause ovulation in women with polycystic ovary syndrome (PCOS). Ovarian drilling is often used by women with PCOS who often do not ovulate despite having attempted weight loss and the use of fertility drugs. According to a 2021 study published on Taylor and Francis online, an American open access journal, the efficacy of ovarian drilling was variable in different literature. Ovulation and pregnancy rates were found to be 30%-90% and 13%-80% respectively.

In December 2021, Organon& Co., an American pharmaceutical company working to improve women’s health, acquired Forendo Pharma for $954 million. Through this acquisition Organon plans to bring innovation in the area of women’s health and develop better treatments. Forendo Pharma is a Finland-based clinical stage pharmaceutical company pioneering in the areas of intracrinology and polycystic ovarian syndrome (PCOS).

Major players in the polycystic ovarian syndrome treatment market are Bristol-Myer Squibb Company, Bayer AG, Pfizer Inc., Merck KGaA, Sanofi, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Limited, Abbott, Addex Therapeutics Ltd., BIOCAD, Allergan PLC., Johnson and Johnson, Ferring BV, and Ferring Pharmaceuticals Inc.

North America was the largest region in the polycystic ovarian syndrome treatment market in 2022. Western Europe was the second largest region in the global polycystic ovarian syndrome treatment market. The regions covered in the global polycystic ovarian syndrome treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the polycystic ovarian syndrome treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The polycystic ovarian syndrome treatment market includes revenue earned by first line drugs for treating hirustism, first line drugs for ovulation, and insulin sensitizing drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global polycystic ovarian syndrome treatment market is segmented -

1) By Drug Type: Oral Contraceptives, Ornithine Decarboxylase Inhibitors, Insulin-Sensitizing Agents, Anti-Depressants, Diuretics, Aromatase Inhibitors

2) By Surgery Type: Ovarian Wedge Resection, Laparoscopic Ovarian Drilling

3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Gynecology Centers, Feminist Health Centers

    Table Of Contents

    1. Executive Summary

    2. Polycystic Ovarian Syndrome Treatment Market Characteristics

    3. Polycystic Ovarian Syndrome Treatment Market Trends And Strategies

    4. Polycystic Ovarian Syndrome Treatment Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Polycystic Ovarian Syndrome Treatment Market

    4.2 Ukraine-Russia War Impact On Polycystic Ovarian Syndrome Treatment Market

    4.3 Impact Of High Inflation On Polycystic Ovarian Syndrome Treatment Market

    5. Polycystic Ovarian Syndrome Treatment Market Size And Growth

    5.1. Global Polycystic Ovarian Syndrome Treatment Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Polycystic Ovarian Syndrome Treatment Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Polycystic Ovarian Syndrome Treatment Market Segmentation

    6.1. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Oral Contraceptives

    Ornithine Decarboxylase Inhibitors

    Insulin-Sensitizing Agents

    Anti-Depressants

    Diuretics

    Aromatase Inhibitors

    6.2. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Surgery Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Ovarian Wedge Resection

    Laparoscopic Ovarian Drilling

    6.3. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals & Clinics

    Ambulatory Surgical Centers

    Diagnostic Centers

    Gynecology Centers

    Feminist Health Centers

    7. Polycystic Ovarian Syndrome Treatment Market Regional And Country Analysis

    7.1. Global Polycystic Ovarian Syndrome Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Polycystic Ovarian Syndrome Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market

    8.1. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Polycystic Ovarian Syndrome Treatment Market

    9.1. China Polycystic Ovarian Syndrome Treatment Market Overview

    9.2. China Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Polycystic Ovarian Syndrome Treatment Market

    10.1. India Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Polycystic Ovarian Syndrome Treatment Market

    11.1. Japan Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Polycystic Ovarian Syndrome Treatment Market

    12.1. Australia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Polycystic Ovarian Syndrome Treatment Market

    13.1. Indonesia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Polycystic Ovarian Syndrome Treatment Market

    14.1. South Korea Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Polycystic Ovarian Syndrome Treatment Market

    15.1. Western Europe Polycystic Ovarian Syndrome Treatment Market Overview

    15.2. Western Europe Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Polycystic Ovarian Syndrome Treatment Market

    16.1. UK Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Polycystic Ovarian Syndrome Treatment Market

    17.1. Germany Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Polycystic Ovarian Syndrome Treatment Market

    18.3. France Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Polycystic Ovarian Syndrome Treatment Market

    19.1. Eastern Europe Polycystic Ovarian Syndrome Treatment Market Overview

    19.2. Eastern Europe Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Polycystic Ovarian Syndrome Treatment Market

    20.1. Russia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Polycystic Ovarian Syndrome Treatment Market

    21.1. North America Polycystic Ovarian Syndrome Treatment Market Overview

    21.2. North America Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Polycystic Ovarian Syndrome Treatment Market

    22.1. USA Polycystic Ovarian Syndrome Treatment Market Overview

    22.2. USA Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Polycystic Ovarian Syndrome Treatment Market

    23.1. South America Polycystic Ovarian Syndrome Treatment Market Overview

    23.2. South America Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Polycystic Ovarian Syndrome Treatment Market

    24.1. Brazil Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Polycystic Ovarian Syndrome Treatment Market

    25.1. Middle East Polycystic Ovarian Syndrome Treatment Market Overview

    25.2. Middle East Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Polycystic Ovarian Syndrome Treatment Market

    26.1. Africa Polycystic Ovarian Syndrome Treatment Market Overview

    26.2. Africa Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Polycystic Ovarian Syndrome Treatment Market Competitive Landscape And Company Profiles

    27.1. Polycystic Ovarian Syndrome Treatment Market Competitive Landscape

    27.2. Polycystic Ovarian Syndrome Treatment Market Company Profiles

    27.2.1. Bristol-Myer Squibb Company

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Bayer AG

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Pfizer, Inc.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Merck KGaA

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Sanofi

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Polycystic Ovarian Syndrome Treatment Pipeline Analysis

    29. Key Mergers And Acquisitions In The Polycystic Ovarian Syndrome Treatment Market

    30. Polycystic Ovarian Syndrome Treatment Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Surgery Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Polycystic Ovarian Syndrome Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Polycystic Ovarian Syndrome Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: China, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: India, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Japan, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: Australia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: Indonesia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: South Korea, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Western Europe, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: UK, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Germany, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: France, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Eastern Europe, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Russia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: North America, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: USA, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South America, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Brazil, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Middle East, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Africa, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Bristol-Myer Squibb Company Financial Performance
  • Table 28: Bayer AG Financial Performance
  • Table 29: Pfizer, Inc. Financial Performance
  • Table 30: Merck KGaA Financial Performance
  • Table 31: Sanofi Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Surgery Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Polycystic Ovarian Syndrome Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Polycystic Ovarian Syndrome Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: China, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: India, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Japan, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: Australia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: Indonesia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: South Korea, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Western Europe, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: UK, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Germany, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: France, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Eastern Europe, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Russia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: North America, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: USA, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South America, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Brazil, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Middle East, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Africa, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Bristol-Myer Squibb Company Financial Performance
  • Figure 28: Bayer AG Financial Performance
  • Figure 29: Pfizer, Inc. Financial Performance
  • Figure 30: Merck KGaA Financial Performance
  • Figure 31: Sanofi Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report